Buy Genmab - ADR Stock | GMAB Stock Price & Latest News | Public

Genmab - ADR

$0.00 (0.00%)Today

About GMAB

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multip...Read more

Community

People who own or watch this stock

News

News image
Wall Street's best-performing analysts like these 5 stocks right now amid the market turmoil
1
0

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

2.1

Price Targets

What analysts think this stock will be worth

$34.75
current
$32.47
average

Events

List of events that could affect this stock.

06May

Earnings data Q1 2020

12Aug

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0.85
0.56
0.28
0
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

$0.07

Actual EPS
Q3 2020

Stats

Market Cap$22,76B
Volume25,27k
Price-to-Earnings Ratio64.34
Dividend Rate
Dividend Yield
1 Year High$35.77
1 Year Low$16.24
Open$35.22
High$35.87
Low$34.75

Buy any stock with any amount of money.

Download the App
Download the app